Adrien Bouglé on Comparison Between Regional Citrate Anticoagulation and Systemic Heparin
Adrien Bouglé, Head of Cardiac ICU and Anesthesiology, Full Professor, Sorbonne University, La Pitié – Salpêtrière, shared on LinkedIn:
”Very pleased to share our latest multicentric study comparing regional citrate anticoagulation and systemic heparin in patients undergoing VA-ECMO and continuous renal replacement therapy.
RCA was associated with a significantly lower risk of CRRT filter thrombosis, without increasing bleeding or severe metabolic complications — supporting its use in this high-risk population.”
Read the full article here.
Article: Comparison between regional citrate anticoagulation and systemic heparin anticoagulation in patients undergoing continuous renal replacement therapy and venoarterial extracorporeal membrane oxygenation: A retrospective multicentric study
Authors: Axel Hirwe, Edris Omar, Pierre-Grégoire Guinot, Antoine Beurton, Nicolas Nesseler, Alexandre Mansour, Vivien Berthoud, Alexandre Ouattara, Stéphanie Rouanet, Guillaume Lebreton, Geoffroy Hariri, Adrien Bouglé
Stay updated on all scientific advances with Hemostasis Today.
-
Jan 18, 2026, 09:53Caitlin Raymond: Practicing at the Edge of ABO – Navigating Rare A Subgroups
-
Jan 18, 2026, 09:48Ed Beveridge Shares A New Guide on VTE Prophylaxis in Psychiatric Illness
-
Jan 18, 2026, 08:11Ardis Callie on Standardisation and Documentation of VTE Risk Assessments
-
Jan 18, 2026, 06:07Alan Nurden Shares A Study on Unusual Form of Glanzmann Thrombasthenia
-
Jan 18, 2026, 05:51Shiny K Kajal on Transfusion Medicine: From Trial and Error to Life-Saving Science
-
Jan 18, 2026, 05:40Abdul Mannan: Why Your Patient on Metformin is Losing B12
-
Jan 17, 2026, 22:13Neil Blumberg on Massive Transfusion in Trauma and Hemorrhagic Emergencies
-
Jan 17, 2026, 14:30Jecko Thachil Shares a Perspective on von Willebrand Disease
-
Jan 17, 2026, 14:16Fadi Alshrouf Explains Red Blood Cell Exchange